Pyng Medical Corp. (V:PYT)
Business Focus: N/A
Apr 03, 2017 06:12 pm ET
Pyng Completes Going-Private Transaction
Pyng Medical Corp. (the "Company" or "Pyng") (TSX VENTURE: PYT) is pleased to announce that it has completed its previously announced plan of arrangement whereby all of the issued and outstanding common shares of Pyng (the "Shares") were acquired by Teleflex Medical Canada Inc., a wholly-owned subsidiary of Teleflex Incorporated (the "Arrangement"). The Arrangement was approved by the Supreme Court of British Columbia in its final order dated March 29, 2017.
Apr 03, 2017 06:12 pm ET
Pyng Completes Going-Private Transaction
Pyng Medical Corp. (the "Company" or "Pyng") (TSX VENTURE:PYT) is pleased to announce that it has completed its previously announced plan of arrangement whereby all of the issued and outstanding common shares of Pyng (the "Shares") were acquired by...
Mar 29, 2017 04:36 pm ET
Pyng Receives Final Order for Acquisition by Teleflex
Pyng Medical Corp. (the "Company" or "Pyng") (TSX VENTURE:PYT) is pleased to announce that the Supreme Court of British Columbia, in its final order dated March 29, 2017, approved the plan of arrangement whereby all of the issued and outstanding...
Mar 29, 2017 04:36 pm ET
Pyng Receives Final Order for Acquisition by Teleflex
Pyng Medical Corp. (the "Company" or "Pyng") (TSX VENTURE: PYT) is pleased to announce that the Supreme Court of British Columbia, in its final order dated March 29, 2017, approved the plan of arrangement whereby all of the issued and outstanding common shares of Pyng (the "Shares") would be acquired by Teleflex Medical Canada Inc., a wholly-owned subsidiary of Teleflex Incorporated (the "Arrangement").
Mar 27, 2017 09:18 pm ET
Pyng Receives Securityholder Approval for Acquisition by Teleflex
Pyng Medical Corp. (the "Company" or "Pyng") (TSX VENTURE: PYT) is pleased to announce that the previously announced acquisition of all of the issued and outstanding common shares of Pyng (the "Shares") by Teleflex Medical Canada Inc., a wholly-owned subsidiary of Teleflex Incorporated, by way of plan of arrangement (the "Arrangement"), has been approved by the holders (the "Securityholders") of Pyng's Shares, options, warrants and convertible debentures. At the special meeting of Pyng Securityholders held on March 27, 2017 (the
Mar 27, 2017 09:18 pm ET
Pyng Receives Securityholder Approval for Acquisition by Teleflex
Pyng Medical Corp. (the "Company" or "Pyng") (TSX VENTURE:PYT) is pleased to announce that the previously announced acquisition of all of the issued and outstanding common shares of Pyng (the "Shares") by Teleflex Medical Canada Inc., a wholly-owned...
Feb 28, 2017 08:34 pm ET
Pyng Medical Corp. Reports First Quarter Fiscal 2017 Results
Pyng Medical Corp. (TSX VENTURE: PYT) today announced financial and operating results for the first quarter fiscal 2017. All amounts are in Canadian dollars unless stated otherwise.
Feb 28, 2017 08:34 pm ET
Pyng Medical Corp. Reports First Quarter Fiscal 2017 Results
Pyng Medical Corp. (TSX VENTURE:PYT) today announced financial and operating results for the first quarter fiscal 2017. All amounts are in Canadian dollars unless stated otherwise.
The Company reported total sales of $2,081,671 for the...
Feb 04, 2017 01:01 pm ET
Teleflex to Acquire Pyng Medical
Pyng Medical Corp. (the "Company" or "Pyng") (TSX VENTURE:PYT) is pleased to announce that the Company has entered into a definitive agreement (the "Arrangement Agreement") with Teleflex Incorporated ("Teleflex") and Teleflex Medical Canada Inc....
Feb 04, 2017 01:01 pm ET
Teleflex to Acquire Pyng Medical
Pyng Medical Corp. (the "Company" or "Pyng") (TSX VENTURE: PYT) is pleased to announce that the Company has entered into a definitive agreement (the "Arrangement Agreement") with Teleflex Incorporated ("Teleflex") and Teleflex Medical Canada Inc. ("Teleflex Medical"), a wholly-owned indirect subsidiary of Teleflex, pursuant to which Teleflex has agreed to cause Teleflex Medical to acquire all of the issued and outstanding common shares of Pyng (the "Shares") for cash consideration of USD $0.30203 per Share (the
Jan 10, 2017 07:43 pm ET
Pyng Medical Corp. Reports Fiscal 2016 Financial Results
Pyng Medical Corp. (TSX VENTURE:PYT) today announced financial and operating results for the fiscal year ended September 30, 2016. All amounts are in Canadian dollars unless stated otherwise.
The Company reported total sales of $5,291,215...
Jan 10, 2017 07:43 pm ET
Pyng Medical Corp. Reports Fiscal 2016 Financial Results
Pyng Medical Corp. (TSX VENTURE: PYT) today announced financial and operating results for the fiscal year ended September 30, 2016. All amounts are in Canadian dollars unless stated otherwise.
Oct 25, 2016 03:53 pm ET
Pyng Medical Completes Note and Warrant Amendments
Pyng Medical Corp. (the "Company") (TSX VENTURE:PYT) is pleased to announce that it has completed amendments to a previously issued secured note in favour of Donatelle Plastics Incorporated ("Donatelle") to provide for the repayment of certain...
Oct 25, 2016 03:53 pm ET
Pyng Medical Completes Note and Warrant Amendments
Pyng Medical Corp. (the "Company") (TSX VENTURE: PYT) is pleased to announce that it has completed amendments to a previously issued secured note in favour of Donatelle Plastics Incorporated ("Donatelle") to provide for the repayment of certain additional invoices of Donatelle in the aggregate amount of US$1.1 million by the Company and to state certain additional terms as agreed by the parties. The Company has also completed amendments (the "Note and Warrant Amendments") to the terms of certain previously issued secured convertible notes in the aggregate
Oct 19, 2016 04:26 pm ET
Pyng Medical Corp. Announces Grant of Stock Options
Pyng Medical Corp. (TSX VENTURE:PYT) (the "Company" or "Pyng") announces that on October 19, 2016 it granted a total of 500,000 options to purchase common shares of the Company to certain Directors, Officers, and Advisory Board Members of the...
Oct 19, 2016 04:26 pm ET
Pyng Medical Corp. Announces Grant of Stock Options
Pyng Medical Corp. (TSX VENTURE: PYT) (the "Company" or "Pyng") announces that on October 19, 2016 it granted a total of 500,000 options to purchase common shares of the Company to certain Directors, Officers, and Advisory Board Members of the Company in accordance with the Company's stock option plan dated March 18, 2005, as amended and restated on March 5, 2008 and March 31, 2011. The options will vest immediately, expire on October 19, 2020 and have an exercise price of $0.05 per common share.
Oct 11, 2016 04:51 pm ET
Pyng Medical Completes Convertible Note and Warrant Amendments
Pyng Medical Corp. (the "Company") (TSX VENTURE: PYT) is pleased to announce that it has completed amendments to the terms of certain previously issued secured convertible notes in the aggregate principal amount of $530,000 (the "2015 Notes") and amendments to the terms of 10,600,000 previously issued warrants with an exercise price of $0.05 per warrant (the "2015 Warrants"). The 2015 Warrants were issued on August 8, 2015 as partial consideration of previous amendments to the 2015 Notes. The Company previously amended the maturity date of the 2015 Notes and the
Oct 11, 2016 04:51 pm ET
Pyng Medical Completes Convertible Note and Warrant Amendments
Pyng Medical Corp. (the "Company") (TSX VENTURE:PYT) is pleased to announce that it has completed amendments to the terms of certain previously issued secured convertible notes in the aggregate principal amount of $530,000 (the "2015 Notes") and...
Sep 08, 2016 10:27 pm ET
Pyng Medical Completes Convertible Note and Warrant Amendments
Pyng Medical Corp. (the "Company") (TSX VENTURE:PYT) is pleased to announce that it has completed amendments to the terms of certain previously issued secured convertible notes in the aggregate principal amount of $530,000 (the "2015 Notes") and...
Sep 08, 2016 10:27 pm ET
Pyng Medical Completes Convertible Note and Warrant Amendments
Pyng Medical Corp. (the "Company") (TSX VENTURE: PYT) is pleased to announce that it has completed amendments to the terms of certain previously issued secured convertible notes in the aggregate principal amount of $530,000 (the "2015 Notes") and amendments to the terms of 10,600,000 previously issued warrants with an exercise price of $0.05 per warrant (the "2015 Warrants"). The 2015 Warrants were issued on August 8, 2015 as partial consideration of previous amendments to the 2015 Notes. The Company previously amended the maturity date of the 2015 Notes and the
Aug 23, 2016 05:00 pm ET
Pyng Medical Corp. Reports Third Quarter Fiscal 2016 Results
Pyng Medical Corp. (TSX VENTURE:PYT) today announced financial and operating results for the three and nine months June 30, 2016. All amounts are in Canadian dollars unless stated otherwise.
The Company reported total sales of $1,336,501...
Aug 23, 2016 05:00 pm ET
Pyng Medical Corp. Reports Third Quarter Fiscal 2016 Results
Pyng Medical Corp. (TSX VENTURE: PYT) today announced financial and operating results for the three and nine months June 30, 2016. All amounts are in Canadian dollars unless stated otherwise.
Aug 09, 2016 05:40 pm ET
Pyng Medical Completes Convertible Note and Warrant Amendments
Pyng Medical Corp. (the "Company") (TSX VENTURE:PYT) is pleased to announce that it has completed amendments to the terms of certain previously issued secured convertible notes in the aggregate principal amount of $530,000 (the "2015 Notes") and...
Aug 09, 2016 05:40 pm ET
Pyng Medical Completes Convertible Note and Warrant Amendments
Pyng Medical Corp. (the "Company") (TSX VENTURE: PYT) is pleased to announce that it has completed amendments to the terms of certain previously issued secured convertible notes in the aggregate principal amount of $530,000 (the "2015 Notes") and amendments to the terms of 10,600,000 previously issued warrants with an exercise price of $0.05 per warrant (the "2015 Warrants"). The 2015 Warrants were issued on August 8, 2015 as partial consideration of previous amendments to the 2015 Notes. The Company amended the maturity date of the 2015 Notes and the expiry
May 24, 2016 08:00 pm ET
Pyng Medical Corp. Reports Second Quarter Fiscal 2016 Results
Pyng Medical Corp. (TSX VENTURE:PYT) today announced financial and operating results for the three and six months March 31, 2016. All amounts are in Canadian dollars unless stated otherwise.
The Company reported total sales of $1,218,080...
May 24, 2016 08:00 pm ET
Pyng Medical Corp. Reports Second Quarter Fiscal 2016 Results
Pyng Medical Corp. (TSX VENTURE: PYT) today announced financial and operating results for the three and six months March 31, 2016. All amounts are in Canadian dollars unless stated otherwise.
May 02, 2016 07:47 pm ET
Pyng Medical Announces Election of Directors and Approval of Stock Option Plan at 2016 Annual General Meeting
Pyng Medical Corp. (the "Company") (TSX VENTURE: PYT) is pleased to announce that at the Annual General Meeting ("AGM") of the shareholders held on April 27, 2016, the following persons were elected as directors: Robert Di Silvio, Dr. Ronald Blanck, L.J. (Bud) Evans Jr., Dr. Alan L. Moloff, and Herbert A. Toms III. The Company's Stock Option Plan dated March 18, 2005, as amended March 5, 2008 and March 31, 2011, was also approved until the next AGM, subject to filing with the TSXV.
May 02, 2016 07:47 pm ET
Pyng Medical Announces Election of Directors and Approval of Stock Option Plan at 2016 Annual General Meeting
Pyng Medical Corp. (the "Company") (TSX VENTURE:PYT) is pleased to announce that at the Annual General Meeting ("AGM") of the shareholders held on April 27, 2016, the following persons were elected as directors: Robert Di Silvio, Dr. Ronald...
Mar 31, 2016 09:35 am ET
Pyng Medical Corp. Announces Grant of Stock Options
Pyng Medical Corp. (TSX VENTURE: PYT) (the "Company" or "Pyng") announces that on March 31, 2016 it granted a total of 180,000 options to purchase common shares of the Company to certain Directors, Officers, and Advisory Board Members of the Company in accordance with the Company's stock option plan dated March 18, 2005, as amended and restated on March 5, 2008 and March 31, 2011. The options will vest immediately, expire on March 31, 2020 and have an exercise price of $0.05 per common share.
Disclaimer :: Use of this site is subject to, and your continued use
constitutes your express agreement to be bound by, our Legal and Terms of Use. Any commercial use of this site is
strictly prohibited. Canadianinsider.com is operated by INK Research Corp (INK). INK provides general information.
INK has made all reasonable efforts to ensure that all information provided is accurate at the time of inclusion;
however, there may be errors. INK makes no guarantee of accuracy or completeness. All information and opinion
expressed herein is subject to change without notice. Read more...Insider information is based on filings made on the System
for Electronic Disclosure for Insiders (SEDI®). Data is provided “as is” and by using this site
you acknowledge that the information which comprises the data is filed by or on behalf of the SEDI filers or other
parties legally required or permitted to do so. Filings may at any time contain errors and by using this site you
acknowledge this fact. INK is not an investment advisory service, a financial planner, an investment advisor nor a
securities advisor. INK does not purport to tell people, or suggest to people, what they should buy or sell for
themselves. Opinions and recommendations contained herein should not be construed as investment advice. Do not
assume that any recommendations, insights, charts, theories, or philosophies will ensure profitable investment.
Users should always consult with and obtain advice from their professional licensed financial advisor, including
their tax advisor, to determine the suitability of any investment. INK recommends that anyone making an investment
or trading securities do so with caution. Users should perform full due diligence and investigate any security
fully before making an investment or before the execution of a security trade based upon information learned
through INK. Investors should obtain annual reports and other company information to complete their own due
diligence in any investment. Neither INK nor anyone affiliated with INK is responsible for any investment decision
made. INK employees may have an ownership or investment interest in any stock mentioned in this service or on this
website. On this site, there may be third party content, content from authors or links to third-party sites or
pages, the contents of which are not verified, maintained, controlled or supervised by INK. INK is not responsible
for and assumes no liability for the accuracy, completeness or timeliness of any third party content or authored
content provided herein or the information or contents of any linked sites or pages. The inclusion of any authored
content or link by us does not imply that INK recommends, approves or endorses the authored content or linked site
or pages. INK Edge® and INK Research® are registered trade-marks owned by INK Research Corp. SEDI®
is a registered trade-mark owned by the Alberta Securities Commission.Read less
Please make the indicated changes including the new text: US quotes snapshot data provided by IEX. Additional price data and company information powered by Twelve Data.
Interactive technical study charts by TradingView. Copyright © 2024 INK Research Corp. All rights reserved. All trade-marks or trade names not owned by INK Research Corp. are the property of their respective owners.
